Image

Breast Cancer Symposium | Evaluation Questionnaire

BCS | Evaluation Questionnaire
(1-Not Likely to 5-Very Likely)
I attest that I have completed this educational activity in its entirety. *
Were faculty disclosures made prior to the start of the CME activity? *

Please rate whether the following educational objectives were met.

Review the recent developments in breast surgical approaches including upfront and after neoadjuvant chemotherapy *
Explain the rationale for reconstruction options post neoadjuvant chemotherapy and radiation therapy *
Discuss updates in breast cancer imaging for earlier detection *
Identify therapeutic advances in early and advanced hormone receptor-positive, HER2 neu overexpressing, and triple-negative breast cancer *
Review the advances in radiation therapy and outcomes including short-course radiation therapy and de-escalation *
Describe the management of HER2 positive early breast cancer in the older patient *
Review the treatment of early-stage inherited breast cancer *
Identify the new and emerging systemic treatment options for breast cancer brain metastases beyond surgery and radiotherapy *
Describe molecular profiling for metastatic breast cancer management n Explain the mechanism of action and rationale for immunotherapy *

Please rate the projected impact of this activity on your knowledge, competence, performance, and patient outcomes:

This activity increased my knowledge. *
This activity increased my competence. *
This activity increased my performance. *
This activity increased my patient outcomes. *

Do you feel the activity was scientifically sound and free of commercial bias or influence?

Do you feel the activity was scientifically sound and free of commercial bias or influence?

Please identify how you will change your practice as a result of attending this activity.

This activity validated my current practice. No changes will be made. *
Create/revise protocols, policies, and/or procedures *
Change the management and/or treatment of my patients *
Please indicate any barriers you perceive in implementing these changes. *
Will you attempt to address these barriers in order to implement changes in your competence, performance, and/or patients' outcomes? *
The content of this activity matched my current (or potential) scope of practice. *

Please rate the following faculty - Friday, September 23rd:

Breast Imaging — Dr. Elizabeth Morris (UC Davis)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

Pathology — Dr. Anna Boguniewicz (AMC)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

Management of Breast and Axilla-Who needs upfront surgery? — Dr. Hiram Cody (MSKCC)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

Management of Breast and Axilla in patients who receive Neoadjuvant Therapy - Dr. Eleftherios Mamounas (OHCI)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

Reconstruction Post NAC and RT - Dr. Babak Mehrara (MSKCC)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

Genetics Related to Breast and Ovarian Cancer - Dr. Elizabeth Poynor (NYU)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

Updates in who should receive and who can avoid Adjuvant Breast Radiation - Dr. Yasmin Hasan (UOC)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

Breast Radiation Update: Short Course RT – Benefits of Downsides and DCIS: Does everyone need RT after conservation surgery? - Dr. Beryl McCormick (MSKCC)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

Please rate the following faculty - Saturday, September 24th:

Molecular Profiling for Metastatic Breast Cancer Management: Who, What, When, and Why? - Dr. Andrew Seidman (MSKCC)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

Optimizing Lifestyle to Improve Cancer Outcomes - Dr. Neil Iyengar (MSKCC)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

Keynote Speaker - Dr. Shanu Modi (MSKCC)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

Leveraging the Lessons 0f Covid19 - Dr. Reshma Mahtani (MCI)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

Early Stage Triple Negative Breast Cancer - Dr. Kevin Kalinsky (EMORY)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

Updates in the Management of Advanced TNBC - Dr. Tiffany Traina (MSKCC)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

Current and Future Directions - Dr. Heather McArthur (UT SMC)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

New and Emerging Systemic Treatment Options for Breast Cancer Brain Metastases: Beyond Surgery and Radiotherapy - Dr. Andrew Seidman (MSKCC)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

Advances in the Treatment of ER+ Early Stage Breast Cancer - Dr. Claudine Isaacs (GU)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

Updates in the Management of Advanced Hormone Positive, HER2 Negative Breast Cancer - Dr. Anne O’Dea (KU)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

Please rate the following faculty - Sunday, September 25th:

Bone Density and Bone Health - Dr. Azeez Farooki (MSKCC)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

Bone Density and Breast Cancer - Dr. Monica Fornier (MSKCC)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

End or Ending a Life - Dr. Monique James (MSKCC)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

HER2nue Early - Dr. Chau Dang (MSKCC)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

HER2nue Late - Dr. VK Gadi (UOIC)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *

Management of HER2-Positive Early Breast Cancer in the Older Patient - Dr. Hyman Muss (UNC)

The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous *
What is your overall evaluation of this CME activity? *